FDA clears 3D MRI application from Siemens Healthineers

Register now

The Food and Drug Administration has approved for clinical use an magnetic resonance imaging-based application from Siemens Healthineers that accelerates three-dimensional diagnostic examinations of the knee.

The company says GOKnee3D reduces scan time for MR imaging of the joint and enables clinically validated push-button isotropic knee exams with all relevant contrasts, enabling evaluation in all imaging planes.

Such examinations are important in ascertaining knee stability or otherwise assessing injuries to the joint, enabling radiologists to better suggest treatment or potential replacement alternatives.

Also See: Virtual reality helps surgeons learn accuracy in crucial injections

GOKnee3D lets radiologists complete a diagnostic 3D knee exam in just 10 minutes, enabled by higher scan speeds and optimal image reconstruction with better signal quality than in previous technologies, company executives say.

The imaging technology is supported by dedicated, high-channel knee coils as well as automated field-of-view adaptation based on machine learning and artificial intelligence.

“The commercial availability of the GOKnee3D MRI application enables dramatically accelerated MR imaging of the knee without compromising on diagnostic quality,” says Murat Gungor, vice president of magnetic resonance imaging at Siemens Healthineers North America. “Faster scanning will help shorten both exam and patient wait times in support of an overall improved patient experience.”

GOKnee3D is available for two of the company’s MRI scanners, and Siemens says it will eventually make it available for use on more of its scanners.

For reprint and licensing requests for this article, click here.